Latigo Biotherapeutics Challenges Vertex Dominance with Strong Phase 2 Data for Non-Opioid Pain Candidate LTG-001
The landscape of pain management, long dominated by the shadow of the opioid crisis and...
The landscape of pain management, long dominated by the shadow of the opioid crisis and...
The landscape of American scientific research is currently weathering a period of profound structural transformation,...
The decision centers on the termination of what policy experts call the "Premium Stabilization Demonstration,"...
The most visible symbol of this friction remains Dr. Anthony Fauci, the former director of...
The high-stakes regulatory drama surrounding Capricor Therapeutics and its lead candidate, deramiocel, reached a fever...
The subpoena comes at a time when the debate over the "lab leak" hypothesis versus...
The escalating crisis within the American Diabetes Association (ADA) reached a fever pitch this week...
The halls of the Hart Senate Office Building are set to become the epicenter of...
In mid-July, the Department of Homeland Security (DHS) announced a final rule that will fundamentally...
The landscape of gynecological health is undergoing a seismic shift, yet long-standing inequities continue to...